F13.281
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F13.281 refers to a condition where an individual develops a dependence on sedative, hypnotic, or anxiolytic medications, which are drugs typically used to manage anxiety, sleep disorders, and related conditions. This dependence is accompanied by sexual dysfunction that is induced by these medications. Such issues can significantly impact quality of life, relationships, and overall well-being. Understanding this condition involves recognizing its causes, symptoms, diagnostic methods, and possible treatment approaches.
Causes & Symptoms
Clinical Causes: Prolonged use or misuse of sedative, hypnotic, or anxiolytic medications, leading to physical or psychological dependence. Prescribing these medications without proper medical oversight or for extended periods. Genetic predisposition that increases vulnerability to addiction. Underlying mental health conditions such as anxiety or insomnia, which may lead to reliance on these drugs. Development of tolerance over time, prompting higher doses to achieve the same effect, increasing the risk of dependence.
Key Symptoms: Craving or compulsive use of sedative, hypnotic, or anxiolytic medications. Inability to reduce or stop medication despite adverse effects. Withdrawal symptoms upon decreasing or discontinuing the drug, such as anxiety, agitation, or sleep disturbances. Development of sexual dysfunction, which may include reduced libido, difficulty achieving orgasm, or erectile problems. Neglect of personal or social responsibilities due to medication use. Use of medication in larger amounts or over longer periods than intended. Persistent desire or unsuccessful efforts to cut down or control medication use.
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a comprehensive assessment including a detailed medical and psychological history, physical examination, and potentially laboratory tests. Healthcare professionals evaluate patterns of medication use, assess for signs of dependence, and investigate the presence of sexual dysfunction. Patient questionnaires and standardized screening tools may be employed to identify substance dependence and associated side effects. It is essential to differentiate between medication side effects and symptoms of underlying health issues.
Treatment Protocols: Supervised medication withdrawal or tapering to safely reduce dependence. Psychotherapy, such as cognitive-behavioral therapy, to address underlying mental health conditions and prevent relapse. Medication management to treat sexual dysfunction, which might involve adjusting current medications or prescribing alternative therapies. Support groups or counseling to provide social support and promote recovery. Monitoring and regular follow-up to assess progress, manage withdrawal symptoms, and prevent relapse.
Clinical Advice & FAQs
Billing Guidance
Is F13.281 a billable ICD-10 code?
Yes, F13.281 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.281?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
